IS7263A - Súlfónamíðaafleiður, framleiðsla þeirra og notkunþeirra sem lyfja - Google Patents

Súlfónamíðaafleiður, framleiðsla þeirra og notkunþeirra sem lyfja

Info

Publication number: IS7263A
Authority: IS; Iceland
Prior art keywords: pharmaceuticals; production; sulphonamide derivatives; sulphonamide; derivatives
Prior art date: 2001-11-14

Application number

IS7263A

Other languages

English (en)

Inventor

Mercé-Vidal Ramon

Andaluz-Mataro Blas

Frigola-Constansa Jordi

Original Assignee

Laboratorios Del Dr. Esteve, S.A.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-11-14

Filing date

2004-05-13

Publication date

2004-05-13

2004-05-13 Application filed by Laboratorios Del Dr. Esteve, S.A. filed Critical Laboratorios Del Dr. Esteve, S.A.

2004-05-13 Publication of IS7263A publication Critical patent/IS7263A/is

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
- C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
- C04B35/00—Shaped ceramic products characterised by their composition; Ceramics compositions; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products
- C04B35/622—Forming processes; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products
- C04B35/626—Preparing or treating the powders individually or as batches ; preparing or treating macroscopic reinforcing agents for ceramic products, e.g. fibres; mechanical aspects section B
- C04B35/63—Preparing or treating the powders individually or as batches ; preparing or treating macroscopic reinforcing agents for ceramic products, e.g. fibres; mechanical aspects section B using additives specially adapted for forming the products, e.g.. binder binders
- C04B35/632—Organic additives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
- C07D209/16—Tryptamines
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Chemical Kinetics & Catalysis (AREA)
Neurology (AREA)
Manufacturing & Machinery (AREA)
Ceramic Engineering (AREA)
Psychiatry (AREA)
Materials Engineering (AREA)
Inorganic Chemistry (AREA)
Structural Engineering (AREA)
Epidemiology (AREA)
Pain & Pain Management (AREA)
Hospice & Palliative Care (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Indole Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Steroid Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

IS7263A 2001-11-14 2004-05-13 Súlfónamíðaafleiður, framleiðsla þeirra og notkunþeirra sem lyfja IS7263A (is)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
ES200102517A ES2187300B1 (es)	2001-11-14	2001-11-14	Derivados de sulfonamidas, su preparacion y su aplicacion como medicamentos.
PCT/ES2002/000518 WO2003042175A1 (es)	2001-11-14	2002-11-08	Derivados de sulfonamidas, su preparación y su aplicación como medicamentos

Publications (1)

Publication Number	Publication Date
IS7263A true IS7263A (is)	2004-05-13

Family

ID=8499446

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
IS7263A IS7263A (is)	2001-11-14	2004-05-13	Súlfónamíðaafleiður, framleiðsla þeirra og notkunþeirra sem lyfja
IS8698A IS8698A (is)	2001-11-14	2007-12-05	Súlfónamíðaafleiður, framleiðsla þeirra og notkunþeirra sem lyfja

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
IS8698A IS8698A (is)	2001-11-14	2007-12-05	Súlfónamíðaafleiður, framleiðsla þeirra og notkunþeirra sem lyfja

Country Status (34)

Country	Link
US (4)	US7105515B2 (is)
EP (2)	EP1445252B1 (is)
JP (2)	JP4416505B2 (is)
KR (1)	KR20040071685A (is)
CN (1)	CN1271052C (is)
AR (1)	AR037288A1 (is)
AT (2)	ATE428694T1 (is)
BR (1)	BR0214243A (is)
CA (1)	CA2466965C (is)
CO (1)	CO5590895A2 (is)
CY (1)	CY1105362T1 (is)
DE (2)	DE60232029D1 (is)
DK (1)	DK1445252T3 (is)
EC (1)	ECSP045105A (is)
ES (4)	ES2187300B1 (is)
HK (1)	HK1070053A1 (is)
HR (1)	HRP20040429B1 (is)
HU (1)	HUP0402317A2 (is)
IL (2)	IL161885A0 (is)
IS (2)	IS7263A (is)
MA (1)	MA27093A1 (is)
MX (1)	MXPA04004601A (is)
NO (1)	NO20042478L (is)
NZ (2)	NZ533136A (is)
PL (1)	PL373894A1 (is)
PT (2)	PT1666462E (is)
RS (1)	RS41104A (is)
RU (2)	RU2293082C2 (is)
SG (1)	SG146442A1 (is)
SI (1)	SI1445252T1 (is)
TW (1)	TWI275585B (is)
UA (1)	UA78252C2 (is)
WO (1)	WO2003042175A1 (is)
ZA (1)	ZA200404073B (is)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2187300B1 (es) *	2001-11-14	2004-06-16	Laboratorios Del Dr. Esteve, S.A.	Derivados de sulfonamidas, su preparacion y su aplicacion como medicamentos.
CA2524682A1 (en) *	2003-05-09	2004-11-18	Laboratorios Del Dr. Esteve S.A.	Use of sulphonamide derivatives for the manufacture of a medicament for the prophylaxis and/or treatment of disorders of food ingestion
ES2222827B1 (es) *	2003-07-30	2006-03-01	Laboratorios Del Dr. Esteve, S.A.	Derivados de 5-indolilsulfonamidas, su preparacion y su aplicacion como medicamentos.
ES2228268B1 (es) *	2003-07-30	2006-07-01	Laboratorios Del Dr. Esteve, S.A.	Combinacion de sustancias activas conteniendo al menos un compuesto con afinidad por el receptor del neuropeptido y (npy) y al menos un compuesto con afinidad por el receptor 5-ht6.
ES2222829B1 (es) *	2003-07-30	2006-03-01	Laboratorios Del Dr. Esteve, S.A.	Derivados de 4-indolilsulfonamidas, su preparacion y su aplicacion como medicamentos.
ES2222832B1 (es) *	2003-07-30	2006-02-16	Laboratorios Del Dr. Esteve, S.A.	Derivados de 6-indolilsulfonamidas, su preparacion y su aplicacion como medicamentos.
ES2228267B1 (es) *	2003-07-30	2006-07-01	Laboratorios Del Dr. Esteve, S.A.	Combinacion de sustancias activas conteniendo al menos un compuesto con afinidad por el receptor del neuropeptido y (npy) y al menos un compuesto con afinidad por el receptor 5-ht6.
ES2222830B1 (es)	2003-07-30	2006-02-16	Laboratorios Del Dr. Esteve, S.A.	Derivados de 7-indolilsulfonamidas, su preparacion y su aplicacion como medicamentos.
SE0303480D0 (sv) *	2003-12-19	2003-12-19	Biovitrum Ab	Benzofuranes
DE602004021031D1 (de) *	2004-01-02	2009-06-18	Suven Life Sciences Ltd	Neue indenoä2,1-aüindene und isoindolä2,1-aüindol
ES2246721B1 (es) *	2004-08-10	2007-03-16	Laboratorios Del Dr. Esteve, S.A.	Compuestos indolicos sustituidos, su preparacion y su uso como medicamentos.
EP1632491A1 (en) *	2004-08-30	2006-03-08	Laboratorios Del Dr. Esteve, S.A.	Substituted indole compounds and their use as 5-HT6 receptor modulators
PL1883451T3 (pl) *	2005-04-13	2011-05-31	Neuraxon Inc	Podstawione związki indolowe mające aktywność hamowania NOS
JP5026690B2 (ja) *	2005-11-21	2012-09-12	株式会社ジャパンディスプレイイースト	表示装置
CA2637933C (en) *	2006-01-24	2013-03-12	Eli Lilly And Company	Indole sulfonamide modulators of progesterone receptors
EP1837332A1 (en) *	2006-03-23	2007-09-26	Laboratorios Del Dr. Esteve, S.A.	Substituted tetrahydroisoquinoline compounds, their preparation and use in medicaments
AR060451A1 (es) *	2006-04-13	2008-06-18	Neuraxon Inc	Compuestos de indol 1,5 y 3,6-sustituidos con actividad inhibitoria de nos
EP1902733A1 (en) *	2006-09-19	2008-03-26	Laboratorios Del Dr. Esteve, S.A.	Combination of a NMDA-receptor ligand and a compound with 5-HT6 receptor affinity
EP1953141A1 (en) *	2007-01-31	2008-08-06	Laboratorios del Dr. Esteve S.A.	Aryl-substituted sulfonamides for the treatment of cognitive or food ingestion related disorders
EP1953153A1 (en) *	2007-01-31	2008-08-06	Laboratorios del Dr. Esteve S.A.	Heterocyclyl-substituted sulfonamides for the treatment of cognitive or food ingestion related disorders
EP2018861A1 (en) *	2007-07-26	2009-01-28	Laboratorios del Dr. Esteve S.A.	5HT6-Ligands such as sulfonamide derivatives in drug-induced weight-gain
ATE495737T1 (de) *	2007-08-01	2011-02-15	Esteve Labor Dr	Kombination von mindestens zwei 5-ht6-liganden
EP2036888A1 (en) *	2007-09-17	2009-03-18	Laboratorios del Dr. Esteve S.A.	Naphthyl-substituted sulfonamides
US20090131503A1 (en) *	2007-11-16	2009-05-21	Annedi Subhash C	3,5 - substituted indole compounds having nos and norepinephrine reuptake inhibitory activity
CN101910157B (zh) *	2007-11-16	2014-05-07	纽尔亚商股份有限公司	吲哚化合物和治疗内脏痛的方法
CA2705422A1 (en) *	2007-11-16	2009-05-22	The Arizona Board Of Regents On Behalf Of The University Of Arizona	Methods for treating visceral pain
EP2116547A1 (en)	2008-05-09	2009-11-11	Laboratorios Del. Dr. Esteve, S.A.	Substituted N-imidazo(2, 1-b) thiazole-5-sulfonamide derivatives as 5-TH6 ligands
EP2116546A1 (en) *	2008-05-09	2009-11-11	Laboratorios Del. Dr. Esteve, S.A.	Substituted N-phenyl-2,3-dihydroimidazo[2,1-b]thiazole-5-sulfonamide derivatives as 5-HT6 ligands
EA029499B9 (ru) *	2013-08-02	2018-07-31	Пфайзер Инк	Ингибиторы rorc2 и способы их применения
MA40759A (fr)	2014-09-26	2017-08-01	Pfizer	Modulateurs de rorc2 de type pyrrolopyridine substitué par un méthyle et trifluorométhyle et leurs procédés d'utilisation

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3472870A (en)	1966-08-29	1969-10-14	Mead Johnson & Co	Sulfonamidotryptamines
US5578612A (en) *	1990-10-15	1996-11-26	Pfizer Inc.	Indole derivatives
KR19980703048A (ko) *	1995-03-20	1998-09-05	피터쥐.스트링거	5-치환-3-(1,2,3,6-테트라히드로피리딘-4-일)- 및 3-(피페리딘-4-일)-1ｈ-인돌: 신규한 5-ｈｔ1ｆ 아고니스트
US5962473A (en) *	1996-08-16	1999-10-05	Eli Lilly And Company	Methods of treating or ameliorating the symptoms of common cold or allergic rhinitis with serotonin 5-HT1F
EP0875513A1 (en) *	1997-04-14	1998-11-04	Eli Lilly And Company	Substituted heteroaromatic 5-HT 1F agonists
US6380201B1 (en) *	1997-08-05	2002-04-30	Eli Lilly And Company	Methods of treating or ameliorating the symptoms of common cold or allergic rhinitis with serotonin 5-HT1F agonists
ES2187300B1 (es) *	2001-11-14	2004-06-16	Laboratorios Del Dr. Esteve, S.A.	Derivados de sulfonamidas, su preparacion y su aplicacion como medicamentos.

2001
- 2001-11-14 ES ES200102517A patent/ES2187300B1/es not_active Expired - Fee Related
2002
- 2002-08-11 UA UA20040604587A patent/UA78252C2/uk unknown
- 2002-11-08 RU RU2004117850/04A patent/RU2293082C2/ru not_active IP Right Cessation
- 2002-11-08 NZ NZ533136A patent/NZ533136A/en unknown
- 2002-11-08 HU HU0402317A patent/HUP0402317A2/hu unknown
- 2002-11-08 AR ARP020104303A patent/AR037288A1/es not_active Application Discontinuation
- 2002-11-08 WO PCT/ES2002/000518 patent/WO2003042175A1/es active Application Filing
- 2002-11-08 EP EP02785439A patent/EP1445252B1/en not_active Expired - Lifetime
- 2002-11-08 DE DE60232029T patent/DE60232029D1/de not_active Expired - Lifetime
- 2002-11-08 AT AT05021228T patent/ATE428694T1/de active
- 2002-11-08 RS YU41104A patent/RS41104A/sr unknown
- 2002-11-08 MX MXPA04004601A patent/MXPA04004601A/es active IP Right Grant
- 2002-11-08 SI SI200230302T patent/SI1445252T1/sl unknown
- 2002-11-08 IL IL16188502A patent/IL161885A0/xx unknown
- 2002-11-08 NZ NZ543393A patent/NZ543393A/en unknown
- 2002-11-08 EP EP05021228A patent/EP1666462B1/en not_active Expired - Lifetime
- 2002-11-08 DK DK02785439T patent/DK1445252T3/da active
- 2002-11-08 ES ES02785439T patent/ES2259387T3/es not_active Expired - Lifetime
- 2002-11-08 PT PT05021228T patent/PT1666462E/pt unknown
- 2002-11-08 CA CA2466965A patent/CA2466965C/en not_active Expired - Fee Related
- 2002-11-08 KR KR10-2004-7007155A patent/KR20040071685A/ko not_active Application Discontinuation
- 2002-11-08 CN CNB028240804A patent/CN1271052C/zh not_active Expired - Fee Related
- 2002-11-08 BR BR0214243-0A patent/BR0214243A/pt not_active IP Right Cessation
- 2002-11-08 JP JP2003544012A patent/JP4416505B2/ja not_active Expired - Fee Related
- 2002-11-08 PT PT02785439T patent/PT1445252E/pt unknown
- 2002-11-08 SG SG200602676-9A patent/SG146442A1/en unknown
- 2002-11-08 PL PL02373894A patent/PL373894A1/xx not_active Application Discontinuation
- 2002-11-08 AT AT02785439T patent/ATE319684T1/de active
- 2002-11-08 ES ES05021228T patent/ES2322068T3/es not_active Expired - Lifetime
- 2002-11-08 DE DE60209779T patent/DE60209779T2/de not_active Expired - Lifetime
- 2002-11-11 TW TW091132989A patent/TWI275585B/zh not_active IP Right Cessation
- 2002-11-13 US US10/293,206 patent/US7105515B2/en not_active Expired - Fee Related
2004
- 2004-05-06 ES ES200401084A patent/ES2249129B2/es not_active Expired - Fee Related
- 2004-05-13 EC EC2004005105A patent/ECSP045105A/es unknown
- 2004-05-13 IS IS7263A patent/IS7263A/is unknown
- 2004-05-14 HR HR20040429A patent/HRP20040429B1/xx not_active IP Right Cessation
- 2004-05-25 ZA ZA200404073A patent/ZA200404073B/en unknown
- 2004-05-26 CO CO04048713A patent/CO5590895A2/es not_active Application Discontinuation
- 2004-06-07 MA MA27723A patent/MA27093A1/fr unknown
- 2004-06-14 NO NO20042478A patent/NO20042478L/no not_active Application Discontinuation
- 2004-09-03 US US10/933,951 patent/US7176200B2/en not_active Expired - Fee Related
2005
- 2005-02-05 HK HK05101004A patent/HK1070053A1/xx not_active IP Right Cessation
- 2005-11-22 RU RU2005136355/04A patent/RU2005136355A/ru not_active Application Discontinuation
2006
- 2006-06-02 CY CY20061100709T patent/CY1105362T1/el unknown
- 2006-07-17 US US11/487,745 patent/US7498328B2/en not_active Expired - Fee Related
2007
- 2007-02-16 US US11/707,571 patent/US7452881B2/en not_active Expired - Fee Related
- 2007-12-05 IS IS8698A patent/IS8698A/is unknown
2008
- 2008-08-04 IL IL193234A patent/IL193234A0/en unknown
2009
- 2009-09-29 JP JP2009223711A patent/JP5132649B2/ja not_active Expired - Fee Related

Also Published As

Publication number	Publication date
NO20042478L (no)	2004-08-12
ES2187300A1 (es)	2003-05-16
PL373894A1 (en)	2005-09-19
ES2249129B2 (es)	2007-08-16
SI1445252T1 (sl)	2006-06-30
CN1271052C (zh)	2006-08-23
AR037288A1 (es)	2004-11-03
JP2009298819A (ja)	2009-12-24
US7105515B2 (en)	2006-09-12
RU2293082C2 (ru)	2007-02-10
JP4416505B2 (ja)	2010-02-17
EP1666462B1 (en)	2009-04-15
MA27093A1 (fr)	2004-12-20
US20070167448A1 (en)	2007-07-19
JP5132649B2 (ja)	2013-01-30
BR0214243A (pt)	2004-12-21
PT1666462E (pt)	2009-05-07
RU2004117850A (ru)	2005-11-20
WO2003042175A1 (es)	2003-05-22
US7176200B2 (en)	2007-02-13
DE60232029D1 (de)	2009-05-28
HRP20040429A2 (en)	2005-06-30
US7452881B2 (en)	2008-11-18
TWI275585B (en)	2007-03-11
US20060258653A1 (en)	2006-11-16
RU2005136355A (ru)	2007-05-27
CY1105362T1 (el)	2010-03-03
NZ543393A (en)	2007-04-27
KR20040071685A (ko)	2004-08-12
EP1666462A1 (en)	2006-06-07
DE60209779D1 (de)	2006-05-04
ES2259387T3 (es)	2006-10-01
JP2005513016A (ja)	2005-05-12
DK1445252T3 (da)	2006-06-19
UA78252C2 (en)	2007-03-15
CA2466965A1 (en)	2003-05-22
CA2466965C (en)	2011-09-06
ES2187300B1 (es)	2004-06-16
US20030191124A1 (en)	2003-10-09
ATE428694T1 (de)	2009-05-15
EP1445252B1 (en)	2006-03-08
ATE319684T1 (de)	2006-03-15
ES2322068T3 (es)	2009-06-16
CN1599718A (zh)	2005-03-23
PT1445252E (pt)	2006-07-31
ES2249129A1 (es)	2006-03-16
HRP20040429B1 (en)	2007-10-31
ECSP045105A (es)	2004-07-23
SG146442A1 (en)	2008-10-30
DE60209779T2 (de)	2006-11-16
MXPA04004601A (es)	2004-08-13
RS41104A (en)	2006-10-27
US20050032791A1 (en)	2005-02-10
IS8698A (is)	2007-12-05
TW200407306A (en)	2004-05-16
HK1070053A1 (en)	2005-06-10
CO5590895A2 (es)	2005-12-30
EP1445252A1 (en)	2004-08-11
ZA200404073B (en)	2006-05-31
NZ533136A (en)	2006-01-27
HUP0402317A2 (hu)	2005-02-28
IL161885A0 (en)	2005-11-20
IL193234A0 (en)	2009-02-11
US7498328B2 (en)	2009-03-03

Publication	Publication Date	Title
IS8698A (is)	2007-12-05	Súlfónamíðaafleiður, framleiðsla þeirra og notkunþeirra sem lyfja
IS7881A (is)	2005-06-02	CHK-, PDK- og AKT-hindrandi pýrimidín, framleiðsla þeirra og notkun sem lyfjaefni
IS2040B (is)	2005-08-15	Pýrasólínafleiður, framleiðsla þeirra og notkun sem lyfja
DK1362027T3 (da)	2008-09-22	Acylerede 6,7,8,9-tetrahydro-5H-benzocycloheptenylaminer og deres anvendelse som farmaceutisk middel
CY2014041I1 (el)	2016-07-27	2,3-διυδρο-6-νιτροϊμιδαζο 2,1 -b-οξαζολια
EG25011A (en)	2011-05-25	Amino-piperidin-1-yl-xanthines, the production thereof and the use of the same as medicaments.
IS6847A (is)	2003-06-16	Eterafleiður, nytsamlegar sem hindrar PDE4 samsætuensíma
ATE539062T1 (de)	2012-01-15	Bizyklishe verbindung, ihre herstellung und verwendung
IL173289A0 (en)	2006-06-11	Substituted thiazole-benzoisothiazole dioxide derivatives, method for the production thereof and use of the same
IS7980A (is)	2005-08-12	Díarýlmetýlídenpíperidínafleiður, framleiðsla þeirra og notkun
ATE303388T1 (de)	2005-09-15	Substituierte 2-pyridinyl-6,7,8,9- tetrahydropyrimidoc1,2-aöpyrimidin-4-on- und 7- pyridinyl-2,3-dihydroimidazo-c1,2-aöpyrimidin- 5(1h)onderivate
IS7829A (is)	2005-04-28	Nýjar 1,4-díazabísýklóalkan-afleiður, framleiðslaþeirra og notkun
ATA7262002A (de)	2003-12-15	Fertigungssystem
DE60221403D1 (de)	2007-09-06	Doppelstrom - verdichter
DE60305332D1 (de)	2006-06-22	IMIDAZOi1,2-AöPYRIDINE
IS2174B (is)	2006-11-15	Setnar fenýl-píperasín afleiður, framleiðsla þeirra og notkun
NO20053588D0 (no)	2005-07-22	Acylaminotiazol-derivater, fremstilling og anvendelse derav som beta-amyloidpeptid-produksjonsinhibitorer.
ATE505459T1 (de)	2011-04-15	Dibenzoäb,füazepin-derivate und ihre herstellung
IS6979A (is)	2003-10-08	5-hluta heteróhringir, framleiðsla og notkun þeirra sem lyfja
MXPA03006648A (es)	2003-10-15	Compuestos antitombroticos, su preparacion y su utilizacion como medicamentos.
IS6403A (is)	2002-05-31	Nýjar heteróarýl afleiður, framleiðsla þeirra og notkun
DE60207451D1 (de)	2005-12-29	Produktionsverfahren
HK1061655A1 (en)	2004-09-30	Caloporoside derivatives, methods for the production thereof and their use
NO20044405L (no)	2004-10-15	Neurotensinaktive 2,3-diaryl-pyrazolidin derivater
IS7131A (is)	2004-01-29	Nýjar 2,4-díamínóþíasól afleiður